Qiang Xu

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Endoplasmic Reticulum Stress

Positive Breast Cancer

Gene Expression

Top Venues

Cell death & disease

Signal transduction and targeted therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaohan Wu, Lingyan Xu, Xiaofei Li, Yirui Zhou, Xiao Han, Wei Zhang, Weicheng Wang, Wenjie Guo, Wen Liu, Qiang Xu, Yan-Hong Gu
A HER2-targeting antibody-MMAE conjugate RC48 sensitizes immunotherapy in HER2-positive colon cancer by triggering the cGAS-STING pathway. Cell death & disease 14 (8) (2023)
Wenwen Xue, Xin Li, Wuhao Li, Yixuan Wang, Chengfei Jiang, Lin Zhou, Jian Gao, Ying Yu, Yan Shen, Qiang Xu
Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer. Signal transduction and targeted therapy 7 (1) (2022)
Fang Xu, Yuxiang Ma, Wei Huang, Jian Gao, Mengmeng Guo, Jianxin Li, Lingdong Kong, Guang Liang, Ronghui Du, Qiang Xu, Xudong Wu
Typically inhibiting USP14 promotes autophagy in M1-like macrophages and alleviates CLP-induced sepsis. Cell death & disease 11 (8) (2020)
Minmin Fan, Jingwei Chen, Jian Gao, Wenwen Xue, Yixuan Wang, Wuhao Li, Lin Zhou, Xin Li, Chengfei Jiang, Yang Sun, Xuefeng Wu, Xudong Wu, Huiming Ge, Yan Shen, Qiang Xu
Triggering a switch from basal- to luminal-like breast cancer subtype by the small-molecule diptoindonesin G via induction of GABARAPL1. Cell death & disease 11 (8) (2020)
Yunlong Shan, Yuan Gao, Wei Jin, Minmin Fan, Ying Wang, Yanhong Gu, Chenxiao Shan, Lijun Sun, Xin Li, Biao Yu, Qiong Luo, Qiang Xu
Targeting HIBCH to reprogram valine metabolism for the treatment of colorectal cancer. Cell death & disease 10 (8) (2019)